337 related articles for article (PubMed ID: 33731281)
1. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca
Zheng X; Li J; Fan Q; Zhao X; Chen K
Int J Cardiol; 2021 Sep; 338():185-195. PubMed ID: 33731281
[TBL] [Abstract][Full Text] [Related]
2. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine alleviates myocardial ischemia-reperfusion injury by down-regulating miR-34b-3p to activate the Jagged1/Notch signaling pathway.
Guo P; Yi H; Han M; Liu X; Chen K; Qing J; Yang F
Int Immunopharmacol; 2023 Mar; 116():109766. PubMed ID: 36764271
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
[TBL] [Abstract][Full Text] [Related]
7. Up-regulating microRNA-138-5p enhances the protective role of dexmedetomidine on myocardial ischemia-reperfusion injury mice via down-regulating Ltb4r1.
Chang Y; Xing L; Zhou W; Zhang W
Cell Cycle; 2021 Feb; 20(4):445-458. PubMed ID: 33509010
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
9. Restoration of NRF2 attenuates myocardial ischemia reperfusion injury through mediating microRNA-29a-3p/CCNT2 axis.
Tian R; Guan X; Qian H; Wang L; Shen Z; Fang L; Liu Z
Biofactors; 2021 May; 47(3):414-426. PubMed ID: 33600051
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA cerebellar degeneration-related protein 1 antisense RNA (Circ-CDR1as) downregulation induced by dexmedetomidine treatment protects hippocampal neurons against hypoxia/reoxygenation injury through the microRNA-28-3p (miR-28-3p)/tumor necrosis factor receptor-associated factor-3 (TRAF3) axis.
Wang J; Wang Y
Bioengineered; 2021 Dec; 12(2):10512-10524. PubMed ID: 34787053
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis.
Zhang X; Li Y; Wang Y; Zhuang Y; Ren X; Yang K; Ma W; Zhong M
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406910
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway.
Wu Y; Qiu G; Zhang H; Zhu L; Cheng G; Wang Y; Li Y; Wu W
J Cell Mol Med; 2021 Nov; 25(21):9983-9994. PubMed ID: 34664412
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine Mitigates Myocardial Ischemia/Reperfusion-Induced Mitochondrial Apoptosis through Targeting lncRNA HCP5.
Deng X; Ye F; Zeng L; Luo W; Tu S; Wang X; Zhang Z
Am J Chin Med; 2022; 50(6):1529-1551. PubMed ID: 35931662
[TBL] [Abstract][Full Text] [Related]
14. microRNA-30e up-regulation alleviates myocardial ischemia-reperfusion injury and promotes ventricular remodeling via SOX9 repression.
Cheng N; Li L; Wu Y; Wang M; Yang M; Wei S; Wang R
Mol Immunol; 2021 Feb; 130():96-103. PubMed ID: 33293097
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of METTL3-Mediated m
Wang X; Li Y; Li J; Li S; Wang F
Cardiovasc Drugs Ther; 2023 Jun; 37(3):435-448. PubMed ID: 35066738
[TBL] [Abstract][Full Text] [Related]
17. Sevoflurane exerts protection against myocardial ischemia-reperfusion injury and pyroptosis through the circular RNA PAN3/microRNA-29b-3p/stromal cell-derived factor 4 axis.
An L; Zhong Y; Tan J; Liu Y; Li A; Yang T; Wang S; Liu Y; Gao H
Int Immunopharmacol; 2023 Jul; 120():110219. PubMed ID: 37270931
[TBL] [Abstract][Full Text] [Related]
18. Inhibited HDAC3 or Elevated MicroRNA-494-3p Plays a Protective Role in Myocardial Ischemia-Reperfusion Injury via Suppression of BRD4.
Zheng W; Xie Q; Zhang Z; Li J; Fang L; Li W
Mol Neurobiol; 2021 Sep; 58(9):4268-4279. PubMed ID: 33982231
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
Cai S; Liu Y; Cheng Y; Yuan J; Fang J
J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841
[TBL] [Abstract][Full Text] [Related]
20. MiR-219a-2 relieves myocardial ischemia-reperfusion injury by reducing calcium overload and cell apoptosis through HIF1α/ NMDAR pathway.
Hu F; Zhang S; Chen X; Fu X; Guo S; Jiang Z; Chen K
Exp Cell Res; 2020 Oct; 395(1):112172. PubMed ID: 32682013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
